RVC Biofund, Quintiles to expand clinical development services

Quintiles and RVC Biofund collaborate to address Russia’s healthcare initiatives in accordance with its Healthcare 2020 Development Program.

This will include implementing best practices to support medical science and the development of healthcare in line with international standards, the companies said.

RVC Biofund CEO Egor Beketov said the partnership will help create high-technology services companies within the Russian Federation to advance biopharma, using RVC Biofund venture capital investments.

"With Quintiles, RVC Biofund gets a partner with the global resources and expertise to further expand development capabilities in Russia," Beketov added.